Depression, Psychotropic Medication, and Risk of Myocardial Infarction: Prospective Data from the Baltimore EGA Follow-up

Circulation

Volumn 94, Issue 12, 1996, Pages 3123-3129

  Pratt, Laura A ^a   Ford, Daniel E ^a,b   Crum, Rosa M ^a,b   Armenian, Haroutune K ^a   Gallo, Joseph J ^a   Eaton, William W ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Depression; Drugs; Myocardial infarction; Risk factors

Indexed keywords

BARBITURIC ACID DERIVATIVE; LITHIUM DERIVATIVE; MEPROBAMATE; PHENOTHIAZINE DERIVATIVE; PSYCHOTROPIC AGENT;

ADULT; AGED; ARTICLE; CORONARY RISK; DEPRESSION; DRUG USE; DYSPHORIA; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; BALTIMORE; COHORT STUDIES; DEMOGRAPHY; DEPRESSIVE DISORDER; EMOTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREVALENCE; PROSPECTIVE STUDIES; PSYCHOTROPIC DRUGS; RISK FACTORS; SEX CHARACTERISTICS; SOCIOECONOMIC FACTORS;

EID: 0030453569     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.12.3123     Document Type: Article

References (38)

1. Malzberg B. Mortality among patients with invulutional melancholia. Am J Psychiatry. 1937;93:1231-1238.
2. Dreyfuss F, Dasberg H, Assael MI. The relationship of myocarclial infarction to depressive illness. Psychother Psychosom. 1969;17: 73-81.
3. Cay EL, Vetter N, Pilip AE, Dugard P. Psychological status during recovery from an acute heart attack. J Psychosom Res. 1972;16: 425-435.
4. Carney RM, Rich MW, Freedland KE, Saini J, teVelde A, Simeone C, Clark K. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med. 1988;50: 627-633.
5. Frasure-Smith N. Lespérance F, Talajic M. Depression and 18month prognosis after myocardial infarction. Circulation. 1995;91: 999-1005.
6. Anda R, Williamson D, Jones D, Macera C, Eaker E, Glassman A, Marks J. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults. Epidemiology. 1993;4: 285-294.
7. Ford DE, Mead LA, Chang PP, Levine DM, Klag MJ. Depression predicts cardiovascular disease in men: the Precursors Study. Circulation. 1994;90(suppl I):I-614. Abstract.
8. Goldberg EL, Comstock GW, Hornstra RK. Depressed mood and subsequent physical illness. Am J Psychiatry. 1979;136:530-534.
9. Vogt T, Pope C, Mullooly J, Hollis J. Mental health status as a predictor of morbidity and mortality: a 15-year follow-up of members of a health maintenance organization. Am J Public Health. 1994;84:227-231.
10. Wassertheil-Smoller S, Applegate WB, Berge K, Chang CJ, Davis BR, Grimm R, Kostis J, Pressel S, Schron E, for the SHEP Cooperative Research Group. Change in depression as a precursor of cardiovascular events. Arch Intern Med. 1996;156:553-561.
11. Glassman AH, Preud'homme XA. Review of the cardiovascular effects of heterocyclic antidepressants. J Clin Psychiatry. 1993;54(2 suppl): 16-22.
12. Goldman LS, Alexander RC, Luchins DJ. Monoamine oxidase inhibitors and tricyclic antidepressants: comparison of their cardiovascular effects. J Clin Psychiatry. 1986;47:225-229.
13. Thorogood M, Cowen P, Mann J, Murphy M, Vessey M. Fatal myocardial infarction and use of psychotropic drugs in young women. Lancet. 1992;340:1067-1068.
14. Lapane KL, Zierler S, Lasater TM, Barbour MM, Carleton R, Hume AL. Is the use of psychotropic drugs associated with increased risk of ischemic heart disease? Epidemiology. 1995;6:376-381.
15. Weissman MM, Markowitz JS, Ouellette R, Greenwald S, Kahn JP. Panic disorder and cardiovascular/cerebrovascular problems: results from a community survey. Am J Psychiatry. 1990;147:1504-1508.
16. Kawachi I, Colditz GA, Ascherio A, Rimm EB, Giovannucci E, Stampfer MJ, Willett WC. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation. 1994;89: 1992-1997.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: American Psychiatric Association; 1980.
18. Eaton WW, Regier DA, Locke BZ, Taube CA. The Epidemiologic Catchment Area Program of the National Institute of Mental Health. Public Health Rep. 1981;96:319-325.
19. Regier DA, Myers JK, Kramer M, Robins LN, Blazer DG, Hough RL, Eaton WW, Locke BZ. The NIMH Epidemiologic Catchment Area program: historical context, major objectives, and study population characteristics. Arch Gen Psychiatry. 1984;41:934-941.
20. Eaton W, Kessler L, eds. Epidemiologic Field Methods in Psychiatry: The NIMH Epidemiologic Catchment Area Program. Orlando, Fla: Academic Press Inc; 1985.
21. Robins LN, Helzer JE, Croughan J, Ratcliff KS. National Institute of Mental Health Diagnostic Interview Schedule: its history, characteristics, and validity. Arch Gen Psychiatry. 1981;38:381-389.
22. Psychotropic drugs and myocardial infarction: cause for or caused by panic? Lancet. 1992:340:1069-1070. Editorial.
23. Stimmel B. Cardiovascular Effects of Mood-altering Drugs. New York, NY: Raven Press; 1979.
24. Tsuang MT, Woolson RF, Fleming JA. Causes of death in schizophrenia and manic-depression. Br J Psychiatry. 1980;136:239-242.
25. Siever LJ, Davis KL. Overview: toward a dysregulation hypothesis of depression. Am J Psychiatry. 1985;142:1017-1031.
26. Haft JI. Cardiovascular injury induced by sympathetic catecholamines. Prog Cardiovasc Dis. 1974;17:73-86.
27. Breslow MJ, Ligier B. Hyperadrenergic states. Crit Care Med. 1991;19:1566-1579.
28. Winokur A, Maislin G, Phillips JL, Amsterdam JD. Insulin resistance after oral glucose tolerance testing in patients with major depression. Am J Psychiatry. 1988;145:325-330.
29. Stout RW. Insulin and atheroma: 20-year perspective. Diabetes Care. 1990;13:631-654.
30. Dalack GW, Roose SP. Perspectives on the relationship between cardiovascular disease and affective disorder. J Clin Psychiatry. 1990; 51:S4-S9.
31. Tretli S, Lund-Larsen PG, Foss OP. Reliability of questionnaire information on cardiovascular disease and diabetes: cardiovascular disease study in Finnmark county. J Epidemiol Community Health. 1982;36:269-273.
32. Colditz GA, Martin P, Stampfer MJ, Willett WC, Sampson L, Rosner B, Hennekens CH, Speizer FE. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol. 1986;123:894-900.
33. Helzer JE, Robins LN, McEvoy LT, Spitznagel EL, Stoltzman RK, Farmer A, Brockington IF. A comparison of clinical and Diagnostic Interview Schedule diagnoses: physician reexamination of lay-interviewed cases in the general population. Arch Gen Psychiatry. 1985;42:657-666.
34. Ladwig KH, Kieser M, König J, Breithardt G, Borggrefe M. Affective disorders and survival after acute myocardial infarction: results from the post-infarction late potential study. Eur Heart J. 1991;12:959-964.
35. Wardle J. Cholesterol and psychological well-being. J Psychosom Res. 1995;39:549-562.
36. Kathol RG, Petty F. Relationship of depression to medical illness: a critical review. J Affective Disorders. 1981;3:111-121.
37. Ahrens B, Muller-Oerlinghausen B, Schou M, Wolf T, Alda M, Grof E, Grof P, Lenz G, Simhandl C, Thau K, Vestergaard P, Wolf R, Möller HJ. Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. J Affect Disord. 1995;33:67-75.
38. Avery D, Winokur G. Mortality in depressed patients treated with electroconvulsive therapy and antidepressants. Arch Gen Psychiatry. 1976;33:1029-1037.